FOXC1 and retinopathy: targeting molecular mechanisms in retinal blood vessel growth

Tsutomu Kume*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1017-1020
Number of pages4
JournalExpert Opinion on Therapeutic Targets
Volume28
Issue number12
DOIs
StatePublished - 2024

Keywords

  • FOXC1
  • VEGF inhibitors
  • angiogenesis
  • blood-retina barrier
  • endothelial cell
  • mTOR
  • pericyte
  • retinal vascular diseases

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this